Premium

Covid 19 coronavirus: Vaccine maker earned record profits but delivered disappointment in return

By Sharon LaFraniere, Chris Hamby and Rebecca R. Ruiz
New York Times·
13 mins to read
Covid 19 coronavirus: Vaccine maker earned record profits but delivered disappointment in return
Emergent was forced to halt operations at its plant in the Bayview area of Baltimore after contamination issues led to millions of spoiled vaccine doses. Photo / Getty Images

Emergent BioSolutions was awarded a US$628 million federal contract with no competitive bidding. Top executives received big bonuses while factories mostly sat idle and tens of millions of Covid-19 doses were thrown away.

Record profits warranted record bonuses. That was the recommendation in January by executives at the biotech firm

Save